These highly methylated and lowly expressed genes, such as Ras association domain family member 1 (RASSF1A) and cyclin‐dependent kinase inhibitor 2A (CDKN2A), were predominantly enriched in multiple cancer‐associated signalling pathways. The gene discussed is CDKN2A; the disease is cancer.